APA (7th ed.) Citation

Ding, Y., Huang, K., Sun, C., Liu, Z., Zhu, J., Jiao, X., . . . Xiong, S. (2024). A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-72121-8

Chicago Style (17th ed.) Citation

Ding, Yangyang, et al. "A Bruton Tyrosine Kinase Inhibitor-resistance Gene Signature Predicts Prognosis and Identifies TRIP13 as a Potential Therapeutic Target in Diffuse Large B-cell Lymphoma." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-72121-8.

MLA (9th ed.) Citation

Ding, Yangyang, et al. "A Bruton Tyrosine Kinase Inhibitor-resistance Gene Signature Predicts Prognosis and Identifies TRIP13 as a Potential Therapeutic Target in Diffuse Large B-cell Lymphoma." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-72121-8.